Anthony Harrelson: Dedicated to Stopping the Spread of Infectious Diseases

Anthony Harrelson is committed to his career in the medical field. He is currently serving as the Chief Executive Officer and Founder of White Oak Industries Inc. White Oak Industries Inc. is a major biopharmaceutical company that is working to develop new immunotherapy treatments in order to stop the spread of some of the world’s most deadly diseases. His company regularly works with infectious diseases such as HIV, Ebola, and some types of Bird Flu. He believes in the work that his company is doing in the field of biodefense, and he also believes in using the power of the body’s own immune system to do the job.

Anthony Harrelson nothing short of an expert in the realm of biodefense and biotechnology within the medical industry. His approach to biodefense against deadly diseases is a unique one; no one else has yet to develop customized immunotherapy by using the virus from the individual host. Not only is this approach unique, but it also harnesses the power of the human immune system to ultimately fight off the disease. Some of the most deadly diseases like HIV and strains of the flu mutate on a regular basis. This means that treating the disease, let alone creating a vaccine, can be incredibly difficult. Not to mention that HIV hides in living tissue that can be severely damaged during treatment for the disease.

Anthony Harrelson, who has a PhD in Microbiology and a Master of Business Administration degree in Finance, is dedicated to the development and commercialization of vaccines that can stop deadly diseases. White Oak Industries Inc. has developed a RNA dendritic stem cell technology that they can program using biological components from each patient. They can employ the patient’s very own dendritic cells in order to activate an immune response specific to the patient’s disease. This approach not only kills the virus at its source, but it also stops the spread and ultimate mutation of the disease in the next host. RNA interference is considered one of the most notable biomedical discoveries made in the last decade because it relies on the patient’s body to destroy the virus. By issuing a response in the patient’s own immune system, the body is able to fight off the specific disease.

When Anthony Harrelson isn’t working to make the world a better place through biopharmaceutical technologies, he can be found making the world a better place through philanthropic work. He enjoys helping people not only through his career, but through his personal life as well. He is a regular giver to local and national charities alike in order to help those who need it most.

The Author writes articles for medical and business field. He has also contributed to Wikipedia, Squidoo and Hubpages. His articles have been published in print as well as online magazines.